Related Experiment Video
Updated: Feb 18, 2026

03:10
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
Published on: November 1, 2024
3.7K
[Acne inversa/hidradenitis suppurativa: An update]
R Sabat1,2, A Tsaousi3,4, J Rossbacher5
1Interdisziplinäre Gruppe Molekulare Immunpathologie, Dermatologie/Med. Immunologie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland. robert.sabat@charite.de.
Summary
Hidradenitis suppurativa (HS), a chronic skin condition, causes painful nodules and scars. This overview summarizes key facts and proposes a simple therapeutic algorithm for managing HS.
Area of Science:
- Dermatology
- Immunology
- Internal Medicine
Background:
- Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic, recurrent, immune-mediated skin disease.
- It manifests as inflammatory nodules, abscesses, fistulas, and scars in apocrine gland-bearing areas.
- Beyond skin issues, HS patients often experience metabolic changes, spondyloarthritis, and depression, significantly impacting quality of life.
Purpose of the Study:
- To provide a comprehensive overview of hidradenitis suppurativa (HS).
- To summarize essential information regarding the pathophysiology, clinical manifestations, and associated comorbidities of HS.
- To propose a straightforward therapeutic algorithm for managing HS.
Main Methods:
- Literature review and synthesis of current knowledge on HS.
- Analysis of clinical characteristics, immune mechanisms, and extra-cutaneous manifestations.
- Development of a simplified treatment guideline based on evidence.
Main Results:
- HS is a complex dermatosis with significant systemic involvement and profound effects on patients' lives.
- Associated conditions include metabolic disturbances, spondyloarthritis, and psychological comorbidities like depression.
- The disease frequently leads to reduced quality of life, social stigmatization, and unemployment.
Conclusions:
- Hidradenitis suppurativa requires a multidisciplinary approach due to its chronic nature and systemic impact.
- Effective management involves understanding the immune basis and associated comorbidities.
- A proposed therapeutic algorithm aims to guide clinicians in treating HS patients effectively.
